S20-258 Chemical Additive Reduces Cost of Manufacturing mRNA Stanford researchers have discovered that ribonucleoside vanadyl complexes can be used as an additive in transcription reactions resulting in ~2-fold increased yield. Eesha Sharma Ivan Zheludev
S20-217 Eterna Enterprise: A Secure Platform for Designing Enhanced mRNA Vaccines Stanford researchers have developed a secured, invite-only version of their popular Eterna platform for designing mRNA vaccines. Rhiju Das Do Soon Kim Jonathan Romano